Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 5/20 | 0.42 |
| ▸ | RARB | P10826 | 4/20 | 0.42 |
| ▸ | RARG | P13631 | 4/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | RXRB | P28702 | 4/20 | 0.39 |
| ▸ | RXRG | P48443 | 3/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | RARA | P10276 | 2/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29608943 | 1.00 | RXRA (0.42) | RXRARARBRARGTP53CYP1A2 | |
| Benzene SCHEMBL1140991 | 0.97 | RXRA (0.44) | RXRARARBRARGTP53CYP1A2 | |
| SCHEMBL13708946 | 0.85 | RXRA (0.39) | RXRARARBRARGTP53CYP1A2 | |
| SCHEMBL24542931 | 0.85 | RARB (0.36) | RXRARARBRARGTP53CYP1A2 | |
| SCHEMBL30312012 | 0.82 | SIGMAR1 (0.40) | RXRARARBRARGTP53RXRB | |
| SCHEMBL23052910 | 0.82 | RXRA (0.34) | RXRARARBRARGTP53CYP1A2 | |
| SCHEMBL30695310 | 0.81 | HTR2A (0.39) | HTR2ANOTUMKDM1A | |
| SCHEMBL2353102 | 0.81 | HTR2A (0.39) | HTR2ANOTUMKDM1A | |
| Terephthalic Acid SCHEMBL9551780 | 0.80 | RXRA (0.67) | RXRARARBRARGCYP1A2RXRB | |
| SCHEMBL10772805 | 0.80 | RARB (0.33) | RXRARARBRARGTP53CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 402 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024125653-A1 | BORON-CONTAINING RESONANCE-TYPE ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 华为技术有限公司 | 2024-06-20 | — | — | WO | claimed |
| CN-114751928-A | Polycyclic aromatic compound and preparation method thereof | 吉林奥来德光电材料股份有限公司 | 2022-07-15 | — | — | CN | claimed |
| US-20200373508-A1 | ELECTROLUMINESCENT MATERIAL INK AND ELECTROLUMINESCENT DEVICE THEREOF | GUANGDONG JUHUA PRINTED DISPLAY TECHNOLOGY CO., LTD. (CN) | 2020-11-26 | — | — | US | claimed |
| US-8633335-B2 | Retinoid prodrug compound | Research Founation Itsuu Laboratory (JP) | 2014-01-21 | — | — | US | claimed |
| EP-1670787-B1 | CYTOKINE INHIBITORS | ITHERX PHARMA INC (US) | 2012-05-30 | — | — | EP | claimed |
| US-20100286427-A1 | RETINOID PRODRUG COMPOUND | RESEARCH FOUNDATION ITSUU LABORATORY (JP) | 2010-11-11 | — | — | US | claimed |
| US-20100273797-A1 | ALPHA-KETOAMIDES AND DERIVATIVES THEREOF | ITHERX PHARMACEUTICALS, INC. | 2010-10-28 | — | — | US | claimed |
| EP-2216322-A1 | RETINOID PRODRUG COMPOUND | Research Foundation Itsuu Laboratory (JP) | 2010-08-11 | — | — | EP | claimed |
| US-20100173896-A1 | Organic Compounds | SAKAKI JUNICHI | 2010-07-08 | — | — | US | claimed |
| US-7749999-B2 | Alpha-ketoamides and derivatives thereof | ITHERX PHARMACEUTICALS, INC. (US) | 2010-07-06 | — | — | US | claimed |
| WO-2005023761-A2 | CYTOKINE INHIBITORS | KEMIA, INC. (US) | 2005-03-17 | — | — | WO | claimed |
| WO-2004089916-A1 | 11-PHENYL-DIBENZODIAZEPINE DERIVATIVES AS RXR-ANTAGONISTS | NOVARTIS AG (CH) | 2004-10-21 | — | — | WO | claimed |
| EP-1294945-A2 | METHOD FOR DETECTING CYTOSINE METHYLATIONS | Epigenomics AG (DE) | 2003-03-26 | — | — | EP | claimed |
| WO-2001098528-A2 | METHOD FOR DETECTING CYTOSINE METHYLATIONS | EPIGENOMICS AG (DE) | 2001-12-27 | — | — | WO | claimed |
| US-5843997-A | Excitatory amino acid receptor antagonists | ELI LILLY AND COMPANY (US) | 1998-12-01 | — | — | US | claimed |
| EP-0837063-A1 | 4-Aminoquinazoline derivatives | PFIZER INC. (US) | 1998-04-22 | — | — | EP | claimed |
| US-5576323-A | CENTRAL NERVOUS SYSTEM DISORDERS | ELI LILLY AND COMPANY (US) | 1996-11-19 | — | — | US | claimed |
| EP-0658539-A1 | Excitatory amino acid receptor antagonists | ELI LILLY AND COMPANY (US) | 1995-06-21 | — | — | EP | claimed |
| EP-0089302-B1 | SUBSTITUTED POLYALKYLATED DERIVATIVES OF 1-INDANONES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN PERFUMES | P. ROBERTET & Cie Société Anonyme dite (FR) | 1985-09-11 | — | — | EP | claimed |
| US-4123469-A | Process for production of bicyclic compounds | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-10-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286427-A1 | RETINOID PRODRUG COMPOUND | STRA6, RXRA, RXRB | RXRA 2/4885RARB 5/4885RARG 7/4885 |
| US-20100273797-A1 | ALPHA-KETOAMIDES AND DERIVATIVES THEREOF | TNF, IL1A, IL1B | RXRA 2273/4885RARB 3068/4885RARG 3242/4885 |
| US-20100173896-A1 | Organic Compounds | RXRB, RXRA, RXRG | RXRA 2/4885RARB 40/4885RARG 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.